MTE 4 INJ
MTE 4 INJ
Discontinued
DIN Number
01945319
Drug Class
Human
Market Date
Dec 31, 1987
Company
HC
lyphomed, division of fujisawa canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01945319
AIG Number0414689003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA30 COMBINATIONS OF ELECTROLYTES
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification88:29.00*
Health Canada Classification
ACTIVE INGREDIENTS (4)
CHROMIUM (CHROMIUM SULFATE)Active
Strength: 4 MCG / ML
Monograph: CHROMIUM (CHROMIUM SULFATE)
COPPER (CUPRIC SULFATE)Active
Strength: .4 MG / ML
Monograph: COPPER (CUPRIC SULFATE)
MANGANESE (MANGANESE SULFATE)Active
Strength: .1 MG / ML
Monograph: MANGANESE (MANGANESE SULFATE)
ZINC (ZINC SULFATE)Active
Strength: 1 MG / ML
Monograph: ZINC (ZINC SULFATE)